Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) just unveiled an update.
Hong Kong’s Securities and Futures Commission has warned of a high concentration of shareholding in Modern Chinese Medicine Group, where 25 shareholders and related parties controlled about 90.6% of issued shares as of 30 March 2026. This leaves only 9.4% of the stock in the hands of other investors, significantly limiting the public float.
The regulator highlighted that such concentration can cause substantial price swings even on small trading volumes, urging existing and prospective investors to exercise extreme caution. The alert follows a sharp surge in the company’s share price, which jumped from HK$0.51 at the end of 2025 to HK$2.94 by mid-April 2026, amplifying concerns about volatility and trading risks for minority shareholders.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd. is a Hong Kong-listed company in the healthcare and pharmaceutical sector, focused on modern Chinese medicine. Its shares trade on the Hong Kong Stock Exchange under stock code 01643, attracting investors exposed to the traditional Chinese medicine market and related health products.
Average Trading Volume: 3,057,414
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.17B
For a thorough assessment of 1643 stock, go to TipRanks’ Stock Analysis page.